Stock Market Reviews

CERT (Certara, Inc.) News

Get the latest news, insights, and market updates on CERT (Certara, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Certara Reports Third Quarter 2025 Financial Results
  Updates Full Year 2025 Financial GuidanceRADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2025. Third Quarter Highlights: Revenue was $104.6 million, compared to $94.8 million in the third quarter of 2024, representing growth of 10%. Software revenue was $43.8 million, compared to $35.9 million in the third quarter of 2024, representing growth
  Nov 6, 2025 - $CERT
• How Certara’s New Cloud-Native TFL Studio (CERT) Has Changed Its Investment Story
  Certara recently launched TFL Studio, the first cloud-native module in its Phoenix Cloud platform, enabling pharmacokinetic and pharmacodynamic professionals to generate regulatory submission materials with greater speed and collaboration. This release highlights Certara's move to cloud and AI-driven solutions, positioning it to further streamline drug development processes across the industry. We'll examine how the introduction of cloud-native TFL Studio reshapes Certara's investment...
  Nov 5, 2025 - $CERT
• Opus Genetics, Inc. (IRD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
  Opus Genetics, Inc. (IRD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  Nov 4, 2025 - $CERT
• Certara Automates Scientific Workflows with Phoenix® Cloud
  New cloud capabilities cut time to create Tables, Figures, and Listings by 50%RADNOR, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of TFL Studio, the first cloud-native module of its Phoenix Cloud solution. TFLs (Tables, Figures, and Listings) present data on study participants, treatments, and outcomes visually for clear interpretation. They are critical components of regulatory submissions an
  Nov 4, 2025 - $CERT
• Certara to Participate in Upcoming Investor Conferences
  RADNOR, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences: UBS Global Healthcare ConferenceDate and Time: Tuesday, November 11th 2025 at 2:00PM ET Jefferies Global Healthcare Conference in LondonDate and Time: Tuesday, November 18th 2025 at 10:30AM GMT Stephens Annual Investment ConferenceDate and Time: Tuesday, November 18th 2025 a
  Oct 31, 2025 - $CERT
• Analysts Estimate Certara, Inc. (CERT) to Report a Decline in Earnings: What to Look Out for
  Certara (CERT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  Oct 30, 2025 - $CERT
• Certara Expands Biosimulation Market with AI-Driven QSP Platform
  Certara IQ™ integrates AI and biosimulation to accelerate R&D productivity, reduce risk, and deepen understanding of novel and complex therapiesRADNOR, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara IQ, a scalable, AI-powered Quantitative Systems Pharmacology (QSP) solution. QSP has rapidly become a cornerstone of modern drug discovery and development with QSP-based FDA submissions hav
  Oct 30, 2025 - $CERT
• Are Investors Undervaluing Certara, Inc. (NASDAQ:CERT) By 40%?
  Key Insights Certara's estimated fair value is US$20.56 based on 2 Stage Free Cash Flow to Equity Certara is estimated...
  Oct 14, 2025 - $CERT
• Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
  RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET. Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance. A live an
  Oct 10, 2025 - $CERT
• What Is Certara, Inc.'s (NASDAQ:CERT) Share Price Doing?
  Certara, Inc. ( NASDAQ:CERT ), might not be a large cap stock, but it saw a decent share price growth of 11% on the...
  Sep 5, 2025 - $CERT